Papers/PMID:29996476
A Pilot Randomized Trial of Oral Magnesium Supplementation on Supraventricular Arrhythmias.
Nutrients2018The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
magnesium(2+) — increases serum magnesium concentration
Evidence strength: moderate.Findingreplicated ×12“Over the 12-week follow-up period, those assigned magnesium supplementation had a significant increase in serum magnesium concentration as compared with those assigned the placebo (0.07 mEq/L; 95% CI: 0.03, 0.12; p = 0.002) (Table 3).”
Quoted verbatim from A Pilot Randomized Trial of Oral Magnesium Supplementation on Supraventricular Arrhythmias.. - Study
- RCT
- Duration
- 3 months
- Dose
- 400 mg magnesium oxide daily
- Population
- Adults aged 55 years or older without prior heart disease, stroke or known kidney disease; 29 randomized to magnesium and 30 to placebo; pilot trial
A Pilot Randomized Trial of Oral Magnesium Supplementation on Supraventricular Arrhythmias.2018PMID:2999647610.3390/nu10070884Permalink